Quest Diagnostics Files 2024 Annual Report
Ticker: DGX · Form: 10-K · Filed: 2025-02-20T00:00:00.000Z
Sentiment: neutral
Topics: annual-report, financials, healthcare
TL;DR
Quest Diagnostics dropped its 2024 10-K. Full financials and outlook inside.
AI Summary
Quest Diagnostics Inc. filed its 2024 10-K on February 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Corning Clinical Laboratories Inc., is a medical laboratory services provider. Key financial details and operational information are presented in this annual report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Quest Diagnostics' financial performance, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a large, publicly traded company in the healthcare sector, Quest Diagnostics faces inherent risks related to regulatory changes, competition, and economic conditions.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 20250220 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Quest Diagnostics Inc. (company) — Filer of the 10-K
- Corning Clinical Laboratories Inc. (company) — Former name of Quest Diagnostics Inc.
- James E. Davis (person) — Mentioned in relation to financial data
- Karthikeyan Kuppusamy (person) — Mentioned in relation to financial data
- 2024-12-31 (date) — Fiscal year end
- 2025-02-20 (date) — Filing date
FAQ
What was Quest Diagnostics' fiscal year end for this filing?
The fiscal year end for this filing was December 31, 2024.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted on February 20, 2025.
What was Quest Diagnostics' former company name?
Quest Diagnostics Inc.'s former company name was Corning Clinical Laboratories Inc.
What is the Standard Industrial Classification (SIC) code for Quest Diagnostics?
The SIC code for Quest Diagnostics is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
What is the SEC file number for Quest Diagnostics?
The SEC file number for Quest Diagnostics is 001-12215.
From the Filing
0001022079-25-000044.txt : 20250220 0001022079-25-000044.hdr.sgml : 20250220 20250220163052 ACCESSION NUMBER: 0001022079-25-000044 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 451 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250220 DATE AS OF CHANGE: 20250220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 25645933 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 10-K 1 dgx-20241231.htm 10-K dgx-20241231 0001022079 2024 FY FALSE James E. Davis 365 Karthikeyan Kuppusamy 270 P5Y P5Y P5Y 31.5 http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD dgx:claim 0001022079 2024-01-01 2024-12-31 0001022079 2024-06-30 0001022079 2025-01-31 0001022079 dgx:JamesE.DavisMember 2024-10-01 2024-12-31 0001022079 dgx:KarthikeyanKuppusamyMember 2024-10-01 2024-12-31 0001022079 2024-10-01 2024-12-31 0001022079 dgx:JamesE.DavisMember 2024-12-31 0001022079 dgx:KarthikeyanKuppusamyMember 2024-12-31 0001022079 2024-12-31 0001022079 2023-12-31 0001022079 2023-01-01 2023-12-31 0001022079 2022-01-01 2022-12-31 0001022079 2022-12-31 0001022079 2021-12-31 0001022079 us-gaap:CommonStockMember 2021-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001022079 us-gaap:RetainedEarningsMember 2021-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2021-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2021-12-31 0001022079 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001022079 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001022079 us-gaap:CommonStockMember 2022-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001022079 us-gaap:RetainedEarningsMember 2022-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2022-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2022-12-31 0001022079 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001022079 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001022079 us-gaap:CommonStockMember 2023-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001022079 us-gaap:RetainedEarningsMember 2023-12-31 0001022079